COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Computational and Systems Biology Seminar Series > Artificial Intelligence in Drug Discovery and Computational Biology: Current Status, Successes, and Pitfalls
Artificial Intelligence in Drug Discovery and Computational Biology: Current Status, Successes, and PitfallsAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Michael Boemo. The amount of chemical and biological data available has increased in the public as well as the private domain, and both on the algorithmic and hardware side progress has been tremendous in machine learning. Press releases describe the design of functional proteins and antibodies from scratch, and several ‘first AI-designed drugs’ have already entered clinical phases. This talk is part of the Computational and Systems Biology Seminar Series series. This talk is included in these lists:Note that ex-directory lists are not shown. |
Other listsThinking Society: What is Life? CMS Seminars Arrol Adam Lecture SeriesOther talksTypological Diversity in NLP: What, Why and a Way Forward Quantitative microbiome profiling in health and disease. Constraints on the Properties of Primordial Protocells Structure Prediction and Design using AlphaFold Alan Turing and the Enigma Machine Analysing Memorisation in Classification and Translation through Localisation and Cartography |